DE69840154D1 - Verfahren zur Diagnose der Alzheimer Erkrankung auf der Basis eines Gen Transkriptionsmusters - Google Patents
Verfahren zur Diagnose der Alzheimer Erkrankung auf der Basis eines Gen TranskriptionsmustersInfo
- Publication number
- DE69840154D1 DE69840154D1 DE69840154T DE69840154T DE69840154D1 DE 69840154 D1 DE69840154 D1 DE 69840154D1 DE 69840154 T DE69840154 T DE 69840154T DE 69840154 T DE69840154 T DE 69840154T DE 69840154 D1 DE69840154 D1 DE 69840154D1
- Authority
- DE
- Germany
- Prior art keywords
- disease
- gene transcription
- disease based
- diagnosing alzheimer
- transcription pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO972006A NO972006D0 (no) | 1997-04-30 | 1997-04-30 | Ny metode for diagnose av sykdommer |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69840154D1 true DE69840154D1 (de) | 2008-12-04 |
Family
ID=19900683
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69828392T Expired - Lifetime DE69828392T2 (de) | 1997-04-30 | 1998-04-30 | Verfahren zur Herstellung eines diagnostischen Standard-Gentranskriptionsmusters |
DE69840154T Expired - Lifetime DE69840154D1 (de) | 1997-04-30 | 1998-04-30 | Verfahren zur Diagnose der Alzheimer Erkrankung auf der Basis eines Gen Transkriptionsmusters |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69828392T Expired - Lifetime DE69828392T2 (de) | 1997-04-30 | 1998-04-30 | Verfahren zur Herstellung eines diagnostischen Standard-Gentranskriptionsmusters |
Country Status (13)
Country | Link |
---|---|
US (4) | US6720138B2 (de) |
EP (3) | EP2050825A1 (de) |
JP (1) | JP4163758B2 (de) |
AT (2) | ATE286143T1 (de) |
AU (1) | AU7222698A (de) |
CY (1) | CY1108716T1 (de) |
DE (2) | DE69828392T2 (de) |
DK (2) | DK1323728T3 (de) |
ES (2) | ES2230688T3 (de) |
HK (2) | HK1026003A1 (de) |
NO (2) | NO972006D0 (de) |
PT (2) | PT1323728E (de) |
WO (1) | WO1998049342A1 (de) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO972006D0 (no) * | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
US20040248169A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of obesity related gene transcripts in blood |
US20040248170A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of hyperlipidemia related gene transcripts in blood |
WO2000040749A2 (en) | 1999-01-06 | 2000-07-13 | Genenews Inc. | Method for the detection of gene transcripts in blood and uses thereof |
US20050003394A1 (en) * | 1999-01-06 | 2005-01-06 | Chondrogene Limited | Method for the detection of rheumatoid arthritis related gene transcripts in blood |
US20060134635A1 (en) * | 2001-02-28 | 2006-06-22 | Chondrogene Limited | Method for the detection of coronary artery disease related gene transcripts in blood |
US20040265868A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of depression related gene transcripts in blood |
US20050123938A1 (en) * | 1999-01-06 | 2005-06-09 | Chondrogene Limited | Method for the detection of osteoarthritis related gene transcripts in blood |
US20040241728A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of lung disease related gene transcripts in blood |
US20070031841A1 (en) * | 2001-02-28 | 2007-02-08 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
US20040241726A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
US7473528B2 (en) | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
US6365376B1 (en) * | 1999-02-19 | 2002-04-02 | E. I. Du Pont De Nemours And Company | Genes and enzymes for the production of adipic acid intermediates |
US7005256B1 (en) | 1999-03-10 | 2006-02-28 | Cold Spring Harbor Laboratory | Gene chip technology for determining memory genes |
AU782926B2 (en) * | 1999-03-10 | 2005-09-08 | Cold Spring Harbor Laboratory | Gene chip technology for determining memory genes |
EP1208228A2 (de) * | 1999-05-19 | 2002-05-29 | Mitokor | Differentielle genexpression in spezifischen regionen vom gehirn in neurodegenerativen erkrankungen |
DK1410011T3 (da) * | 2001-06-18 | 2011-07-18 | Netherlands Cancer Inst | Diagnose og prognose for brystcancerpatienter |
US20050064446A1 (en) * | 2001-11-01 | 2005-03-24 | Minerva Biotechnologies Corporation | Detection of binding species with colloidal and non-colloidal structures |
GB0227238D0 (en) * | 2002-11-21 | 2002-12-31 | Diagenic As | Product and method |
US7790867B2 (en) | 2002-12-05 | 2010-09-07 | Rosetta Genomics Inc. | Vaccinia virus-related nucleic acids and microRNA |
FR2853907B1 (fr) * | 2003-04-18 | 2007-08-03 | Commissariat Energie Atomique | Procede de preparation de fragments d'adn par fragmentation selective d'acides nucleiques et ses applications |
US7888497B2 (en) * | 2003-08-13 | 2011-02-15 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof |
WO2005076939A2 (en) * | 2004-02-09 | 2005-08-25 | University Of Kentucky Research Foundation | Assay and method for diagnosing and treating alzheimer’s disease |
US7593483B2 (en) * | 2004-05-07 | 2009-09-22 | Broadcom Corporation | Nonlinear mapping in digital-to-analog and analog-to-digital converters |
US7687616B1 (en) | 2004-05-14 | 2010-03-30 | Rosetta Genomics Ltd | Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof |
AU2005243410B2 (en) | 2004-05-14 | 2010-04-22 | Rosetta Genomics Ltd. | Micronas and uses thereof |
US7795419B2 (en) | 2004-05-26 | 2010-09-14 | Rosetta Genomics Ltd. | Viral and viral associated miRNAs and uses thereof |
CA2572450A1 (en) | 2004-05-28 | 2005-12-15 | Ambion, Inc. | Methods and compositions involving microrna |
GB0412301D0 (en) * | 2004-06-02 | 2004-07-07 | Diagenic As | Product and method |
US7867703B2 (en) * | 2004-08-26 | 2011-01-11 | Agilent Technologies, Inc. | Element defined sequence complexity reduction |
US7713693B1 (en) | 2004-09-01 | 2010-05-11 | University Of Louisiana At Monroe | Human cancer cell specific gene transcript |
EP2302055B1 (de) | 2004-11-12 | 2014-08-27 | Asuragen, Inc. | Verfahren und Zusammensetzungen, die miRNAs und miRNAa-inhibitorischen Molekülen verbunden sind |
EP2520669A3 (de) * | 2005-02-07 | 2013-02-27 | GeneNews Inc. | Biomarker für milde Arthrose und Verwendungen davon |
US20070082350A1 (en) * | 2005-02-09 | 2007-04-12 | Philip Landfield | Assay and method for diagnosing and treating alzheimer's disease |
GB2449819A (en) * | 2006-02-28 | 2008-12-03 | Univ California | Genes differentially expressed in bipolar disorder and/or schizophrenia |
WO2008036765A2 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
EP2145001A2 (de) * | 2006-09-19 | 2010-01-20 | Asuragen, Inc. | Von mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulierte gene und stoffwechselwege als ziele für einen therapeutischen eingriff |
US20090029868A1 (en) * | 2006-10-31 | 2009-01-29 | Applera Corporation | Expression signature in peripheral blood for detection of aortic aneurysm |
CA2671194A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-20 regulated genes and pathways as targets for therapeutic intervention |
WO2008073915A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Micrornas differentially expressed in leukemia and uses thereof |
EP2104737B1 (de) * | 2006-12-08 | 2013-04-10 | Asuragen, INC. | Funktionen und ziele von let-7-mikro-rnas |
CA2671294A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-21 regulated genes and pathways as targets for therapeutic intervention |
US20090175827A1 (en) * | 2006-12-29 | 2009-07-09 | Byrom Mike W | miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
US20090232893A1 (en) * | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
EP2167138A2 (de) * | 2007-06-08 | 2010-03-31 | Asuragen, INC. | Mir-34-regulierte gene und pfade als targets für therapeutische intervention |
US8361714B2 (en) * | 2007-09-14 | 2013-01-29 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
US20090186015A1 (en) * | 2007-10-18 | 2009-07-23 | Latham Gary J | Micrornas differentially expressed in lung diseases and uses thereof |
WO2009070805A2 (en) * | 2007-12-01 | 2009-06-04 | Asuragen, Inc. | Mir-124 regulated genes and pathways as targets for therapeutic intervention |
US20090192114A1 (en) * | 2007-12-21 | 2009-07-30 | Dmitriy Ovcharenko | miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
WO2009100430A2 (en) * | 2008-02-08 | 2009-08-13 | Asuragen, Inc | miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS |
WO2009154835A2 (en) * | 2008-03-26 | 2009-12-23 | Asuragen, Inc. | Compositions and methods related to mir-16 and therapy of prostate cancer |
WO2009126726A1 (en) * | 2008-04-08 | 2009-10-15 | Asuragen, Inc | Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
EP2990487A1 (de) | 2008-05-08 | 2016-03-02 | Asuragen, INC. | Zusammensetzungen und verfahren in zusammenhang mit der mirna-modulation von neovaskularisation oder angiogenese |
KR20110057188A (ko) * | 2008-08-27 | 2011-05-31 | 하. 룬트벡 아크티에 셀스카브 | 바이오마커 프로파일 측정 시스템 및 방법 |
US20100179213A1 (en) * | 2008-11-11 | 2010-07-15 | Mirna Therapeutics, Inc. | Methods and Compositions Involving miRNAs In Cancer Stem Cells |
GB201000688D0 (en) | 2010-01-15 | 2010-03-03 | Diagenic Asa | Product and method |
EP3214174B1 (de) | 2010-03-04 | 2019-10-16 | InteRNA Technologies B.V. | Mirna-molekül, das über seine quelle definiert ist, und seine diagnostischen und therapeutischen verwendungen bei mit emt assoziierten krankheiten |
NZ704322A (en) | 2010-07-06 | 2016-07-29 | Interna Technologies Bv | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
CA2817882C (en) | 2010-11-17 | 2022-08-23 | Asuragen, Inc. | Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms |
EP2474617A1 (de) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | MIR zur Behandlung von Neoangiogenese |
US9222085B2 (en) | 2011-02-03 | 2015-12-29 | Mirna Therapeutics, Inc. | Synthetic mimics of MIR-124 |
WO2012158238A2 (en) | 2011-02-28 | 2012-11-22 | University Of Iowa Research Foundation | Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender |
US9746458B2 (en) * | 2011-04-27 | 2017-08-29 | Loma Linda University Medical Center | Dynactin subunit p62 biomarker for neurological conditions |
US9644241B2 (en) | 2011-09-13 | 2017-05-09 | Interpace Diagnostics, Llc | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease |
WO2013063519A1 (en) | 2011-10-26 | 2013-05-02 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
WO2013063544A1 (en) | 2011-10-27 | 2013-05-02 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
WO2013064702A2 (en) | 2011-11-03 | 2013-05-10 | Diagenic Asa | Probes for diagnosis and monitoring of neurodegenerative disease |
WO2014007623A1 (en) | 2012-07-03 | 2014-01-09 | Interna Technologies B.V. | Diagnostic portfolio and its uses |
WO2014055117A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
US9868992B2 (en) | 2013-03-15 | 2018-01-16 | Baylor Research Institute | Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
WO2014151551A1 (en) | 2013-03-15 | 2014-09-25 | Baylor Research Institute | Ulcerative colitis (uc)-associated colorectal neoplasia markers |
EP2970909A4 (de) | 2013-03-15 | 2017-02-15 | The University of Chicago | Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität |
CA3079524A1 (en) | 2017-11-03 | 2019-05-09 | Interna Technologies B.V. | Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation |
WO2020210521A2 (en) | 2019-04-12 | 2020-10-15 | The Regents Of The University Of California | Compositions and methods for increasing muscle mass and oxidative metabolism |
WO2024028794A1 (en) | 2022-08-02 | 2024-02-08 | Temple Therapeutics BV | Methods for treating endometrial and ovarian hyperproliferative disorders |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981783A (en) | 1986-04-16 | 1991-01-01 | Montefiore Medical Center | Method for detecting pathological conditions |
US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
JP2802125B2 (ja) | 1989-06-23 | 1998-09-24 | キヤノン株式会社 | 核酸の検出方法 |
US5614192A (en) * | 1989-07-19 | 1997-03-25 | Connective Therapeutics, Inc. | T cell receptor peptides as therapeutics for immune-related disease |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
EP0534640B1 (de) * | 1991-09-23 | 1996-10-02 | Pfizer Inc. | Verfahren für die Detektion von spezifische mRNS und DNS in Zellen |
GB2260811B (en) | 1991-10-23 | 1995-07-05 | Yorkshire Cancer Research Camp | Detection of malignant tumours |
JPH07507446A (ja) | 1992-03-04 | 1995-08-24 | シナプティック・ファーマスーティカル・コーポレーション | タウリン及びgabaの輸送体をコードするdna並びにその使用 |
US6114114A (en) | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
EP0667920B1 (de) * | 1992-10-29 | 2003-01-15 | Thomas Jefferson University | Methoden zur detektion von mikrometastasen bei prostata-krebs |
US5633137A (en) | 1992-12-01 | 1997-05-27 | The University Of South Florida | Method for measuring specific gene expression: transcriptional activity per gene dose |
US5677125A (en) | 1994-01-14 | 1997-10-14 | Vanderbilt University | Method of detection and diagnosis of pre-invasive cancer |
WO1997027317A1 (en) | 1996-01-23 | 1997-07-31 | Affymetrix, Inc. | Nucleic acid analysis techniques |
US5830645A (en) * | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US6156502A (en) | 1995-12-21 | 2000-12-05 | Beattie; Kenneth Loren | Arbitrary sequence oligonucleotide fingerprinting |
US6228575B1 (en) | 1996-02-08 | 2001-05-08 | Affymetrix, Inc. | Chip-based species identification and phenotypic characterization of microorganisms |
AU4327697A (en) | 1996-08-20 | 1998-03-06 | Motorola, Inc. | Method and apparatus for detecting predetermined molecular structures in a sample |
AU722819B2 (en) * | 1996-12-06 | 2000-08-10 | Urocor, Inc. | Diagnosis of disease state using mRNA profiles |
US6235474B1 (en) | 1996-12-30 | 2001-05-22 | The Johns Hopkins University | Methods and kits for diagnosing and determination of the predisposition for diseases |
US6190857B1 (en) * | 1997-03-24 | 2001-02-20 | Urocor, Inc. | Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
NO972006D0 (no) * | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
US5994076A (en) | 1997-05-21 | 1999-11-30 | Clontech Laboratories, Inc. | Methods of assaying differential expression |
WO1999006831A2 (en) | 1997-07-29 | 1999-02-11 | Dorssers Lambert C J | Breast cancer resistance genes, methods for their detection and uses thereof |
US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
DE69934222T2 (de) | 1998-02-25 | 2007-10-25 | The United States Government As Represented By The Department Human Services | Zellulare anordnungen für schnelle molekulare profilidentifizierung |
US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
CN1313908A (zh) | 1998-08-21 | 2001-09-19 | 纳克斯科尔公司 | 使用可交联的固定的核酸的检测法 |
US6593084B2 (en) | 1998-10-13 | 2003-07-15 | Robert E. Bird | Carcinogen assay |
AU1115200A (en) | 1998-10-13 | 2000-05-01 | Clontech Laboratories, Inc. | Nucleic acid arrays |
EP1131470A4 (de) | 1998-10-28 | 2004-11-10 | Vysis Inc | Zelluläre arrays sowie verfahren zur detektion und verwendung von markern für genetische störungen |
WO2000026412A1 (en) | 1998-11-02 | 2000-05-11 | Kenneth Loren Beattie | Nucleic acid analysis using sequence-targeted tandem hybridization |
US20040241727A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of schizophrenia related gene transcripts in blood |
US20040248170A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of hyperlipidemia related gene transcripts in blood |
US20040241728A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of lung disease related gene transcripts in blood |
US20040241726A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
US20050003394A1 (en) * | 1999-01-06 | 2005-01-06 | Chondrogene Limited | Method for the detection of rheumatoid arthritis related gene transcripts in blood |
WO2000040749A2 (en) * | 1999-01-06 | 2000-07-13 | Genenews Inc. | Method for the detection of gene transcripts in blood and uses thereof |
US20040265869A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of type II diabetes related gene transcripts in blood |
US7473528B2 (en) * | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
US20040248169A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of obesity related gene transcripts in blood |
US20040265868A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of depression related gene transcripts in blood |
US20050042630A1 (en) * | 1999-01-06 | 2005-02-24 | Chondrogene Limited | Method for the detection of asthma related gene transcripts in blood |
US20020169560A1 (en) * | 2001-05-12 | 2002-11-14 | X-Mine | Analysis mechanism for genetic data |
-
1997
- 1997-04-30 NO NO972006A patent/NO972006D0/no unknown
-
1998
- 1998-04-30 DE DE69828392T patent/DE69828392T2/de not_active Expired - Lifetime
- 1998-04-30 AT AT98919350T patent/ATE286143T1/de active
- 1998-04-30 DK DK03075068T patent/DK1323728T3/da active
- 1998-04-30 DK DK98919350T patent/DK0979308T3/da active
- 1998-04-30 EP EP08015742A patent/EP2050825A1/de not_active Withdrawn
- 1998-04-30 PT PT03075068T patent/PT1323728E/pt unknown
- 1998-04-30 DE DE69840154T patent/DE69840154D1/de not_active Expired - Lifetime
- 1998-04-30 WO PCT/GB1998/001261 patent/WO1998049342A1/en active IP Right Grant
- 1998-04-30 JP JP54675698A patent/JP4163758B2/ja not_active Expired - Fee Related
- 1998-04-30 ES ES98919350T patent/ES2230688T3/es not_active Expired - Lifetime
- 1998-04-30 PT PT98919350T patent/PT979308E/pt unknown
- 1998-04-30 ES ES03075068T patent/ES2316693T3/es not_active Expired - Lifetime
- 1998-04-30 EP EP03075068A patent/EP1323728B1/de not_active Expired - Lifetime
- 1998-04-30 AT AT03075068T patent/ATE412003T1/de active
- 1998-04-30 AU AU72226/98A patent/AU7222698A/en not_active Abandoned
- 1998-04-30 EP EP98919350A patent/EP0979308B1/de not_active Expired - Lifetime
-
1999
- 1999-10-29 US US09/429,003 patent/US6720138B2/en not_active Expired - Fee Related
-
2000
- 2000-08-16 HK HK0105132A patent/HK1026003A1/xx not_active IP Right Cessation
-
2003
- 2003-12-05 US US10/727,576 patent/US20040121390A1/en not_active Abandoned
- 2003-12-31 HK HK03109502.9A patent/HK1057217A1/xx not_active IP Right Cessation
-
2004
- 2004-01-27 NO NO20040371A patent/NO327084B1/no not_active IP Right Cessation
-
2005
- 2005-06-10 US US11/149,370 patent/US20050227286A1/en not_active Abandoned
-
2009
- 2009-01-21 CY CY20091100076T patent/CY1108716T1/el unknown
-
2013
- 2013-07-01 US US13/932,615 patent/US20130337446A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2230688T3 (es) | 2005-05-01 |
ES2316693T3 (es) | 2009-04-16 |
ATE412003T1 (de) | 2008-11-15 |
US20020022222A1 (en) | 2002-02-21 |
ATE286143T1 (de) | 2005-01-15 |
JP4163758B2 (ja) | 2008-10-08 |
JP2001526534A (ja) | 2001-12-18 |
EP1323728A3 (de) | 2004-02-04 |
US20130337446A1 (en) | 2013-12-19 |
EP0979308A1 (de) | 2000-02-16 |
DE69828392D1 (de) | 2005-02-03 |
NO327084B1 (no) | 2009-04-20 |
WO1998049342A1 (en) | 1998-11-05 |
PT1323728E (pt) | 2009-01-23 |
EP0979308B1 (de) | 2004-12-29 |
NO20040371L (no) | 1999-12-14 |
PT979308E (pt) | 2005-03-31 |
US20040121390A1 (en) | 2004-06-24 |
DK1323728T3 (da) | 2009-03-02 |
CY1108716T1 (el) | 2014-04-09 |
AU7222698A (en) | 1998-11-24 |
US6720138B2 (en) | 2004-04-13 |
US20050227286A1 (en) | 2005-10-13 |
EP2050825A1 (de) | 2009-04-22 |
NO972006D0 (no) | 1997-04-30 |
EP1323728B1 (de) | 2008-10-22 |
DE69828392T2 (de) | 2005-12-01 |
EP1323728A2 (de) | 2003-07-02 |
HK1026003A1 (en) | 2000-12-01 |
DK0979308T3 (da) | 2005-04-18 |
HK1057217A1 (en) | 2004-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69840154D1 (de) | Verfahren zur Diagnose der Alzheimer Erkrankung auf der Basis eines Gen Transkriptionsmusters | |
ATE188745T1 (de) | Verfahren zur detektion einer nukleinsaeure mittels einer nukleinsaeuresonde, das ein spezifisches einfangen und eine detektion auf einmal erlaubt | |
WO2000077260A8 (en) | Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms | |
EP1215495A3 (de) | Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern | |
JP2006503587A5 (de) | ||
GB2383043A (en) | Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain | |
ATE333517T1 (de) | Verfahren und sondenset zur erkennung von krebs | |
DE60326153D1 (de) | Verfahren zur diagnose von morbus alzheimer | |
WO2002074911A3 (en) | Identification of gene expression alterations underlying the aging process in mammals | |
DE69129192D1 (de) | Verfahren und reagenzien für die karakterisierung von hla-drbeta-dns | |
ATE213279T1 (de) | Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus | |
US6291186B1 (en) | Method for screening for unknown organisms | |
DE60121547T2 (de) | Elektrochemisches Verfahren zum Nachweis von Nukleinsäuren | |
DE602006018038D1 (de) | Molekulares verfahren zur diagnose von prostatakrebs | |
CN103397089A (zh) | 一种用于染色体数目异常快速检测的半特异性扩增引物组、方法及试剂盒 | |
DE69535023D1 (de) | Ein diagnose-verfahren und ein testsatz für die bestimmung des kell blutgruppln-nenotyps | |
CN113215253B (zh) | 用于评估鼠类肿瘤模型中的免疫反应的方法和组合物 | |
DE69914940D1 (de) | Diagnostische methode basierend auf der function eines proteins das in einer zellfreien umgebung produziert wird, ausgehend von einer probe von nukleinsäuren | |
JPH04135498A (ja) | 遺伝子検出方法 | |
ATE478147T1 (de) | Aus einem neuroblastom isolierte nukleinsäuren | |
ATE373013T1 (de) | In vitro verfahren zur diagnose von neoplastischen erkrankungen durch analyse des methylierungsstatus des cdh4 gens, oligonukleotide und kits zur durchführung eines solchen verfahrens | |
ATE369426T1 (de) | Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen | |
US20020012941A1 (en) | Method for screening for unknown organisms | |
WO1999024607A3 (en) | DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI) | |
ATA12952001A (de) | Verfahren zur genetischen diagnose von hämochromatose sowie sonden zur genetischen diagnose von hämochromatose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |